Under construction – not a live service
Sign in
Taking people in BelgiumNo phase

Observes a balloon catheter procedure to treat irregular heartbeat in atrial fibrillation

Follows adults with atrial fibrillation who receive a radiofrequency balloon catheter treatment.

Plain-language title generated from the registry record
Registry title: Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter

Key facts

Where
Brussels, BelgiumSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Source: NCT06333327, who can take part

Where in Belgium

  • UZ Brussel Heart Rhythm Management CenterBrussels, BelgiumTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Universitair Ziekenhuis Brussel
Trial code
NCT06333327
Record updated
27 March 2024
Original description
All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) "Heliostar" (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.Read full original descriptionShow less

Multielectrode Radiofrequency Balloon for Atrial Fibrillation Catheter Ablation: A Multicenter Real-World Experience

All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) "Heliostar" (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.

Inclusion: symptomatic atrial fibrillation with indication to catheter ablation.

Exclusion: age <18 years old; pregnancy; any contraindications to catheter ablation.

ClinicalTrials.gov NCT06333327